The genetic basis of sleep disorders

Current Pharmaceutical Design

Volumn 14, Issue 32, 2008, Pages 3386-3395

  Dauvilliers, Yves ^a   Tafti, Mehdi ^b  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Association; Genetic; HLA; Linkage; Narcolepsy; RLS; Sleep; Twins

Indexed keywords

APOLIPOPROTEIN E4; AQUAPORIN 2; ATAXIN 3; BETA ADRENERGIC RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR2 ANTIGEN; HOMEODOMAIN PROTEIN; LEPTIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MYOTONIC DYSTROPHY PROTEIN KINASE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; NITRIC OXIDE SYNTHASE; OREXIN; OREXIN 2 RECEPTOR; PER2 PROTEIN; PRION PROTEIN; PROTEIN BTBD9; PROTEIN MEISI; PROTEIN PHOX2B; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE RECEPTOR DELTA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LBXCOR1; UNCLASSIFIED DRUG;

CATAPLEXY; FATAL FAMILIAL INSOMNIA; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; HYPERSOMNIA; INSOMNIA; MONOZYGOTIC TWINS; MOTOR DYSFUNCTION; MYOTONIC DYSTROPHY; NARCOLEPSY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NOCTURNAL ENURESIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; REVIEW; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP WALKING; GENE; GENETIC PREDISPOSITION; GENETICS; PHYSIOLOGY;

GENES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; SLEEP DISORDERS;

EID: 58949090078     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208786549308     Document Type: Review

References (102)

1. Dauvilliers Y, Maret S, Tafti M. Genetics of normal and pathological sleep in humans. Sleep Med Rev 2005; 9: 91-100.
2. Jones CR, Campbell SS, Zone SE, Cooper F, DeSano A, Murphy PJ, et al. Familial advanced sleep-phase syndrome: A short-period circadian rhythm variant in humans. Nature Med 1999; 5: 1062-5.
3. Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 2001; 291: 1040-3.
4. Buhr A, Biancchi MT, Baur R, Courtet P, Pignay V, Boulenger JP, et al. Functional characterization of the new human GABA(A) receptor mutation beta3(R192H). Hum Genet 2002; 111: 154-60.
5. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000; 6: 991-7.
6. Goldfarb LG, Petersen RB, Tabaton M, Brown P, Le Blanc AC, Montagna P, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: Disease phenotype determined by a DNA polymorphism. Science 1992; 258: 806-8.
7. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007; 369: 499-511.
8. Dauvilliers Y, Montplaisir J, Molinari N, Carlander B, Ondze M, Besset A, et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology 2001; 57: 2029-33.
9. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000; 27: 469-74.
10. Dauvilliers Y, Tafti M. Molecular genetics and treatment of narcolepsy. Ann Med 2006; 38: 252-62.
11. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000; 355: 39-40.
12. Dauvilliers Y, Baumann CR, Carlander B, Bischof M, Blatter T, Lecendreux M, et al. CSF hypocretin1 levels in narcolepsy, Kleine Levin syndrome and other hypersomnia and neurological conditions. J Neurol Neurosurg Psychiatry 2003; 74: 1667-73.
13. American Academy of Sleep Medicine. The international Classification of Sleep Disorders - Revised: Chicago IL; 2005.
14. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999; 98: 365-76.
15. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammel T, Lee C, et al. Narcolepsy in orexin knockout mice, molecular genetics of sleep regulation. Cell 1999; 98: 437-51.
16. Hara J, Beukmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001; 30: 345-54.
17. Juji T, Satake M, Honda Y, Doi Y. HLA antigens in Japanese patients with narcolepsy: All the patients were DR2 positive. Tissue Antigens 1984; 24: 316-9.
18. Mignot E, Lin L, Rogers W, Honda Y, Qiu X, Lin X, et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsycataplexy in three ethnic groups. Am J Hum Genet 2001; 68: 686-99.
19. Siebold C, Hansen B, Wyer J, Harlos K, Esnouf RE, Svejgaard A, et al. Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy. Proc Natl Acad Sci USA 2004; 101: 1999-2004.
20. Tafti M, Dauvilliers Y, Overeem S. Narcolepsy and familial advanced sleep-phase syndrome: Molecular genetics of sleep disorders. Curr Opion Genet Dev 2007; 17: 222-7.
21. Dauvilliers Y, Neidhart E, Lecendreux M, Billard M, Tafti M. MAO-A and COMT polymorphisms and gene effects on narcolepsy. Mol Psychiatry 2001; 6: 367-72.
22. Hohjoh H, Terada N, Kawashima M, Honda Y, Tokunaga K. Significant association of the tumor necrosis factor receptor 2 (TNFR2) gene with human narcolepsy. Tissue Antigens 2000; 56: 446-8.
23. Wieczorek S, Jagiello P, Arning L, Dahmen N, Epplen JT. Screening for candidate gene regions in narcolepsy using a microsatellite based approach and pooled DNA. J Mol Med 2004; 82: 696-705.
24. Nakayama J, Miura M, Honda M, Miki T, Honda Y, Arinami T. Linkage of human narcolepsy with HLA association to chromosome 4p13q21. Genomics 2000; 65: 84-6.
25. Dauvilliers Y, Blouin JL, Neidhart E, Carlander B, Eliaou JF, Antonarakis SE, et al. A susceptibility locus maps to a 5Mb region of chromosome 21q. Ann Neurol 2004; 56: 382-8.
26. Kawashima M, Tamiya G, Oka A, Hohjoh H, Juji T, Ebisawa T, et al. Genomewide association analysis of human narcolepsy and a new resistance gene. Am J Hum Genet 2006; 79: 252-63.
27. Arnulf I, Zeitzer JM, File J, Farber N, Mignot E. Kleine-Levin syndrome: a systematic review of 186 cases in the literature. Brain 2005; 128: 2763-76.
28. Dauvilliers Y, Mayer G, Lecendreux M, Neidhart E, PeraitaAdrados R, Sonka K, et al. Kleine-Levin syndrome: An autoimmune hypothesis based on clinical and genetic analyses. Neurology 2002; 59: 1739-45
29. Katz JD, Ropper AH. Familial Kleine-Levin syndrome: Two siblings with unusually long hypersomnic spells. Arch Neurol 2002; 59: 1959-61.
30. Bahammam AS, Gadelrab MO, Owais SM, Alswat K, Hamam KD. Clinical characteristics and HLA typing of a family with KleineLevin syndrome. Sleep Med 2008; 9: 575-8.
31. Arnulf I, Lin L, Gadoth N, File J, Lecendreux M, Franco P, et al. Kleine-Levin syndrome: A systematic study of 108 patients. Ann Neurol 2008; 63: 482-93.
32. Harley HG, Brook JD, Rundle SA, Crow S, Reardon W, Buckler AJ, et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992; 355: 545-6.
33. Laberge L, Begin P, Montplaisir J, Mathieu J. Sleep complaints in patients with myotonic dystrophy. J Sleep Res 2004; 13: 95-100.
34. Manni R, Zucca C, Martinetti M, Ottolini A, Lanzi G, Tartara A. Hypersomnia in dystrophia myotonica: A neurophysiological and immunogenetic study. Acta Neurol Scand 1991; 84: 498-502.
35. Gibbs JW, 3rd, Ciafaloni E, Radtke RA. Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy. Sleep 2002; 25: 672-5.
36. Ciafaloni E, Mignot E, Sansone V, Hilbert JE, Lin L, Lin X, et al. The hypocretin neurotransmission system in myotonic dystrophy type 1. Neurology 2008; 70: 226-30.
37. Lugaresi E, Medori R, Montagna P, Baruzzi A, Cortelli P, Lugaresi A, et al. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 1986; 315: 997-1003.
38. Montagna P, Gambetti P, Cortelli P, Lugaresi E. Familial and sporadic fatal insomnia. Lancet Neurol 2003; 2: 167-76.
39. Dauvilliers Y, Cervena K, Carlander B, Espa F, Bassetti C, Claustrat B, et al. Dissociation in circadian rhythms in a pseudohypersomnia form of fatal familial insomnia. Neurology 2004; 63: 2416-8.
40. Dauvilliers Y, Morin C, Cervena K, Carlander B, Touchon J, Besset A, et al. Family studies in insomnia. J Psychosom Res 2005; 58: 271-8.
41. Beaulieu-Bonneau S, LeBlanc M, Merette C, Dauvilliers Y, Morin CM. Family history of insomnia in a population-based sample. Sleep. 2007; 30: 1739-45.
42. Drake CL, Scofield H, Roth T. Vulnerability to insomnia: The role of familial aggregation. Sleep Med. 2008; 9: 297-302.
43. Hublin C, Kaprio J, Partinen M, Heikkila K, Koskenvuo M. Prevalence and genetics of sleepwalking: A population-based twin study. Neurology 1997; 48: 177-81.
44. Bakwin H. Sleep-walking in twins. Lancet 1970; 2: 446-7.
45. Gregory AM. A genetic decomposition of the association between parasomnias and dyssomnias in 8-year-old twins. Arch Pediatr Adolesc Med 2008; 162: 299-304.
46. Pressman MR. Factors that predispose, prime and precipitate NREM parasomnias in adults: Clinical and forensic implications. Sleep Med Rev 2007; 11: 5-30.
47. Lecendreux M, Bassetti C, Dauvilliers Y, Mayer G, Neidhart E, Tafti M. HLA and genetic susceptibility to sleepwalking. Mol Psychiatry 2003; 8: 114-7.
48. von Gontard A, Schaumburg H, Hollmann E, Eiberg H, Ritting S. The genetics of enuresis: A review. J Urol 2001; 166: 2438-43.
49. Hublin C, Kaprio J, Partinen M, Koskenvuo M. Nocturnal enuresis in a nationwide twin cohort. Sleep 1998; 21: 579-85.
50. Wang QW, Wen JG, Zhang RL, Yang HY, Su J, Liu K, et al. Family and segregation studies: 411 Chinese children with primary nocturnal enuresis. Pediatr Int 2007; 49: 618-22.
51. Bakwin H. Enuresis in twins. Am J Dis Child 1971; 121: 222-5.
52. Eiberg H, Berendt I, Mohr J. Assignment of dominant inherited nocturnal enuresis (ENUR1) to chromosome 13q. Nat Genet 1995; 10: 354-6.
53. Arnell H, Hjalmas K, Jagervall M, Lackgren G, Stenberg A, Bengtsson B, et al. The genetics of primary nocturnal enuresis: Inheritance and suggestion of a second major gene on chromosome 12q. J. Med. Genet 1997; 34: 360-5.
54. Eiberg H. Total Genome Scan Analysis in a single extended family for primary nocturnal enuresis. Evidence for a new locus (ENUR3) for primary nocturnal enuresis on chromosome 22q11. Eur Urol 1998; 33: 34-5.
55. von Gontard A, Eiberg H, Hollmann E, Rittig S, Lehmkuhl G. Molecular genetics of nocturnal enuresis: Clinical and genetic heterogeneity. Acta Paediatr 1998; 87: 571-8.
56. Deen PM, Dahl N, Caplan MJ. The aquaporin-2 water channel in autosomal dominant primary nocturnal enuresis. J Urol 2002; 167: 1447-50.
57. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J, et al. Restless legs syndrome: Diagnostic criteria, special considerations and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4: 101-19.
58. Whittom S, Dauvilliers Y, Pennestri MH, Vercauteren F, Molinari N, Petit D, et al. Age-at-onset in restless legs syndrome: A clinical and polysomnographic study. Sleep Med 2007; 9: 54-9.
59. Desautels A, Turecki G, Montplaisir J, Brisebois K, Sequeira A, Adam B, et al. Evidence for a genetic association between monoamine oxidase A and restless legs syndrome. Neurology 2002; 59: 215-9.
60. Ondo WG, Vuong KD, Wang Q. Restless legs syndrome in monozygotic twins, clinical correlates. Neurology 2000; 55: 1404-6.
61. Xiong L, Jang K, Montplaisir J, Levchenko A, Thibodeau P, Gaspar C, et al. Canadian restless legs syndrome twin study. Neurology. 2007; 68: 1631-3.
62. Ekbom KA. Restless legs: A clinical study. Acta Med Scand 1945; 158(Suppl): 1-123.
63. Montplaisir J, Godbout R, Boghen D, DeChamplain J, Young SN, Lapierre G. Familial restless legs with periodic movements in sleep. Electrophysiological, biochemical, and pharmacological study. Neurology 1985; 35: 130-4.
64. Winkelmann J, Muller-Myhsok B, Wittchen HU, Hock B, Prager M, Pfister H, et al. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol 2002; 52: 297-302.
65. Desautels A, Turecki G, Montplaisir J, Sequeira A, Verner A, Rouleau GA. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet 2001; 69: 1266-70.
66. Desautels A, Turecki G, Montplaisir J, Xiong L, Walters AS, Ehrenberg BL, et al. Restless legs syndrome: Confirmation of linkage to chromosome 12q, genetic heterogeneity, and evidence of complexity. Arch Neurol 2005; 62: 591-5.
67. Desautels A, Turecki G, Xiong L, Rochefort D, Montplaisir J, Rouleau GA, et al. Mutational analysis of neurotensin in familial restless legs syndrome. Mov Disord 2004; 19: 90-4.
68. Xiong L, Dion P, Montplaisir J, Levchenko A, Thibodeau P, Karemera L, et al. Molecular genetic studies of DMT1 on 12q in French-Canadian restless legs syndrome patients and families. Am J Med Genet B Neuropsychiatr Genet 2007; 144: 911-7.
69. Bonati MT, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari, et al. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain 2003; 126: 1485-92.
70. Chen S, Ondo WG, Rao S, Li L, Chen Q, Wang Q. Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p. Am J Hum Genet 2004; 74: 876-85.
71. Pichler I, Marroni F, Volpato CB, Gusella JF, Klein C, Casari G, et al. Linkage analysis identifies a novel locus for restless legs syndrome on chromosome 2q in a South Tyrolean population isolate. Am J Hum Genet 2006; 79: 716-23.
72. Levchenko A, Provost S, Montplaisir JY, Xiong L, St-Onge J, Thibodeau P, et al. A novel autosomal dominant restless legs syndrome locus maps to chromosome 20p13. Neurology 2006; 67: 900-1.
73. Lohmann-Hedrich K, Neumann A, Kleensang A, Lohnau T, Muhle H, Djarmati A, et al. Evidence for linkage of restless legs syndrome to chromosome 9p: Are there two distinct loci? Neurology 2008; 70: 686-94.
74. Kemlink D, Plazzi G, Vetrugno R, Provini F, Polo O, Stiasny-Kolster K, et al. Suggestive evidence for linkage for restless legs syndrome on chromosome 19p13. Neurogenetics 2008; 9: 75-82.
75. Winkelmann J, Schormair B, Lichtner P, Ripke S, Xiong L, Jalilzadeh et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nature Genet 2007; 39: 1000-6.
76. Stefansson H, Rye DB, Hicks A, Petursson H, Ingason A, Thorgeirsson TE, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007; 357: 639-47.
77. Vilarino-Guell C, Farrer MJ, Lin SC. A genetic risk factor for periodic limb movements in sleep. N Eng J Med 2008; 358: 425-7.
78. Winkelmann J, Lichtner P, Schormair B, Uhr M, Hauk S, Stiasny-Kolster K, et al. Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome. Mov Disord 2008; 23: 350-8.
79. Schormair B, Kemlink D, Roeske D, Eckstein G, Xiong L, Lichtner P, et al. PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet 2008; 40: 946-8.
80. Guilleminault C, Partinen M, Hollman K, Powell N Stoohs R. Familial aggregates in obstructive sleep apnea syndrome. Chest 1995; 107: 1545-51.
81. Redline S, Tishler PV. The genetics of sleep apnea. Sleep Med. Rev 2000; 4: 583-602.
82. Riha RL, Diefenbach K, Jennum P, McNicholas WT. Genetic aspects of hypertension and metabolic disease in the obstructive sleep apnoea-hypopnoea syndrome. Sleep Med Rev 2008; 12: 49-63.
83. Teculescu, D, Mauffret-Stephan E, Gaultier C. Familial predisposition to snoring. Thorax 1994; 49: 95.
84. Mathur R, Douglas NJ. Family studies in patients with the sleep apnea-hypopnea syndrome. Ann Intern Med 1995; 122: 174-8.
85. Sundquist J, Li X, Friberg D, Hemminki K, Sundquist K. Obstructive sleep apnea syndrome in siblings: An 8-year Swedish follow-up study. Sleep 2008; 31: 817-23.
86. Patel SR, Larkin EK, Redline S. Shared genetic basis for obstructive sleep apnea and adiposity measures. Int J Obes (Lond) 2008; 32: 795-800.
87. Palmer LJ, Buxbaum SG, Larkin E, Patel SR, Elston RC, Tishler PV, et al. A whole genome scan for obstructive sleep apnea and obesity. Am J Hum Genet 2003; 72: 340-50.
88. Amiel J, Laudier B, Attie-Bitach T, Trang H, de Pontual L, Gener B, et al. Polyalanine expansion and frame-shift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet 2003; 33: 459-61.
89. Dematteis M, Pepin JL, Jeanmart M, Deschaux C, Labarre-Vila A, Levy P. Charcot MarieTooth disease and sleep apnoea syndrome, a family study. Lancet 2001; 357: 267-72.
90. Kadotani H, Kadotani T, Young T, Peppard PE, Finn L, Colrain IM, et al. Association between apolipoprotein E epsilon4 and sleep disordered breathing in adults. JAMA 2001; 285: 2888-90.
91. Foley DJ, Masaki K, White L, Redline S. Relationship between apolipoprotein E epsilon4 and sleep-disordered breathing at different ages. JAMA 2001; 286: 1447-8.
92. Gottlieb DJ, DeStefano AL, Foley DJ, Mignot E, Redline S, Givelber RJ, et al. APOE epsilon-4 is associated with obstructive sleep apnea/ hypopnea: The sleep heart health study. Neurology 2004; 63: 664-8.
93. O'Hara R, Schröder CM, Kraemer HC, Kryla N, Cao C, Miller E, et al. Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon-4 carriers. Neurology 2005; 65: 642-4.
94. Kalra M, Pal P, Kaushal R, Amin RS, Dolan LM, Fitz K, et al. Association of ApoE genetic variants with obstructive sleep apnea in children. Sleep Med 2008; 9: 260-5.
95. Gozal D, Capdevila OS, Kheirandish-Gozal L, Crabtree VM. APOE epsilon 4 allele, cognitive dysfunction, and obstructive sleep apnea in children. Neurology 2007; 69: 243-9.
96. Boström KB, Hedner J, Melander O, Grote L, Gullberg B, Råstam L, et al. Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension. J Hypertens 2007; 25: 779-83.
97. Patel SR, Larkin EK, Mignot E, Lin L, Redline S. The association of angiotensin converting enzyme (ACE) polymorphisms with sleep apnea and hypertension. Sleep 2007; 30: 531-3.
98. Lavie L, Lotan R, Hochberg I, Herer P, Lavie P, Levy AP. Haptoglobin polymorphism is a risk factor for cardiovascular disease in patients with obstructive sleep apnea syndrome. Sleep 2003; 26: 592-5.
99. Piérola J, Barceló A, de la Peña M, Barbé F, Soriano JB, Sánchez Armengol A, et al. Beta3-Adrenergic receptor Trp64Arg polymorphism and increased body mass index in sleep apnoea. Eur Respir J 2007; 30: 743-7.
100. Bartels NK, Börgel J, Wieczorek S, Büchner N, Hanefeld C, Bulut D, et al. Risk factors and myocardial infarction in patients with obstructive sleep apnea: Impact of beta2-adrenergic receptor polymorphisms. BMC Med. 2007 Jan 1; 5: 1.
101. Hanaoka M, Yu X, Urushihata K, Ota M, Fujimoto K, Kubo K. Leptin and leptin receptor gene polymorphisms in obstructive sleep apnea syndrome. Chest 2008; 133: 79-85.
102. Popko K, Gorska E, Wasik M, Stoklosa A, Pywaczewski R, Winiarska M, et al. Frequency of distribution of leptin receptor gene polymorphism in obstructive sleep apnea patients. J Physiol Pharmacol 2007; 58: 551-61.